Search

everythinglearnresearchcommunity

for

Search:↓

New gel formulas without ethanol and propylene glycol, containing a minoxidil-methyl-β-cyclodextrin complex, have been created for treating hair loss.

Genomic approach finds new possible treatments for hair loss.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

Invasomes effectively deliver drugs through the skin and have potential for improved treatments.

Microemulsions could improve skin drug delivery but face challenges like complex creation and potential toxicity.

Hidden fungal infections might cause heart disease and clogged arteries.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Hair follicle organoids can help study hair biology and disorders but need improvements for wider use.

KRDQN effectively predicts adverse drug reactions with high accuracy and clear explanations.

Advanced hydrogels can autonomously deliver drugs to treat radiation skin injuries, but challenges remain for clinical use.

Smart microneedles using advanced tech could improve psoriasis treatment.

Quercetin-loaded nanogels show promise for treating alopecia effectively.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

KAP-depleted hair causes less immune response and is more biocompatible for implants.

Innovative methods are reducing animal testing and improving biomedical research.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

The document concludes that proper diagnosis and treatment of follicular disorders are crucial, with specific treatments for conditions like acne, drug-induced eruptions, and rosacea.

Genetic variants can affect valproic acid's effectiveness, side effects, and levels in epilepsy treatment.

Nanocarriers can improve drug delivery through the skin by overcoming barriers.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Ethosomes improve finasteride delivery through skin for hair loss treatment.

Improving topical drug delivery involves overcoming skin barriers and using personalized dosing to enhance effectiveness.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Scientists created tiny particles that release medicine on the skin and in hair, working better at certain pH levels and being safe for skin cells.

Infrared light can trigger drug release from gold nanoparticle carriers in hair follicles.

SLVs help maintain muscle stretch sensitivity and could aid in treating hypertension and muscle spasticity.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.